All Stories

  1. A systems approach identifies MERTK as a therapeutic vulnerability in ZFTA-RELA-driven ependymomas

    Article • Proceedings of the National Academy of Sciences, February 2026, Proceedings of the National Academy of Sciences

    Taran Gujral

  2. Computational modeling identifies multitargeted kinase inhibitors as effective therapies for metastatic, castration-resistant prostate cancer

    Article • Proceedings of the National Academy of Sciences, September 2021, Proceedings of the National Academy of Sciences

    Taran Gujral

  3. Organotypic tumor slice cultures provide a versatile platform for immuno-oncology and drug discovery

    Article • OncoImmunology, October 2019, Taylor & Francis

    Senior Business Development Manager Ramya Sivakumar, Taran Gujral